Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

COVENANT PEDIATRICS PA

NPI: 1932521630 · MATTHEWS, NC 28105 · Primary Care Clinic/Center · NPI assigned 01/14/2014

$5.06M
Total Medicaid Paid
213,723
Total Claims
161,135
Beneficiaries
64
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialEMEZIE, ANTHONIA (PRESIDENT)
NPI Enumeration Date01/14/2014

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 17,004 $513K
2019 14,814 $513K
2020 13,611 $498K
2021 27,872 $763K
2022 52,037 $1.03M
2023 43,244 $943K
2024 45,141 $801K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 14,611 12,144 $1.35M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 16,744 13,394 $1.06M
99199 Unlisted special service, procedure or report 86,226 51,448 $500K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 3,508 3,066 $323K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 3,087 2,779 $286K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 5,281 4,405 $194K
86003 971 877 $172K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 1,664 1,448 $169K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 6,156 5,317 $160K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 6,913 6,126 $126K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 1,312 1,170 $124K
90472 Immunization administration, each additional vaccine (list separately) 3,542 3,193 $109K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 6,840 5,967 $91K
D0145 Oral evaluation for a patient under three years of age 2,139 1,928 $69K
96110 Developmental screening, with scoring and documentation, per standardized instrument 5,924 5,328 $62K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1,572 1,376 $58K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 907 666 $40K
D1206 Topical application of fluoride varnish 2,137 1,929 $30K
69210 738 674 $24K
96127 5,090 4,433 $22K
87807 1,646 1,352 $22K
81003 9,229 7,868 $15K
90474 480 433 $9K
36415 Collection of venous blood by venipuncture 2,576 2,244 $6K
83655 400 373 $5K
90651 290 256 $5K
0071A 79 69 $5K
85018 2,338 2,041 $4K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 42 34 $3K
92551 7,183 6,332 $3K
0072A 42 36 $3K
90670 1,097 992 $2K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 154 128 $2K
99173 7,826 6,912 $1K
99441 69 36 $1K
90686 921 816 $995.60
99383 15 14 $935.68
90734 91 76 $809.45
99442 20 13 $730.61
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 35 26 $545.49
97802 83 78 $499.17
G9919 Screening performed and positive and provision of recommendations 28 16 $438.20
90620 74 63 $386.10
90723 550 494 $363.68
94664 28 27 $311.98
90649 55 39 $268.74
90633 509 458 $178.98
90715 80 71 $86.76
90688 33 29 $70.04
90656 348 319 $49.74
90647 799 710 $29.84
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 12 12 $0.81
90700 24 24 $0.00
90707 26 26 $0.00
90655 56 56 $0.00
90710 30 30 $0.00
90658 106 102 $0.00
91307 139 115 $0.00
90680 516 458 $0.00
90696 29 29 $0.00
90657 12 12 $0.00
99000 178 144 $0.00
90619 80 75 $0.00
36416 33 29 $0.00